EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Generation of human antibodies targeting human platelet antigen ( HPA) ‐1a

Janita J Oosterhoff iD, Federica Linty, Remco Visser, Thijs de Vos, Suzanne Hofstede-van Egmond, Miranda van de Weerd, Leendert Porcelijn, Masja de Haas, Ellen van der Schoot, Gestur Vidarsson

Transfusion · 2024

DOI: 10.1111/trf.17758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von Janita J Oosterhoff und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Immunohematology, Sanquin Research, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Antigens, Human Platelet, Thrombocytopenia, Neonatal Alloimmune, Isoantibodies. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Landsteiner Foundation for Blood Transfusion Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a condition during pregnancy, which can lead to thrombocytopenia and a bleeding tendency with intracranial hemorrhage (ICH) being the most concerning complication in the fetus or neonate. An incompatibility between human platelet antigen (HPA)‐1a accounts for the majority of FNAIT cases. Binding of HPA‐1a‐specific alloantibodies to their target on fetal platelets and endothelial cells can induce apoptosis of megakaryocytes, disrupt platelet function, and impair angiogenesis. Currently, there is no screening program to identify pregnancies at risk for severe disease. A better understanding of HPA‐1a‐specific antibody heterogeneity in FNAIT could aid in identifying pathogenic antibody properties linked to severe disease. Study Design and Methods This study aimed to isolate HPA‐1a‐specific B‐cells from an HPA‐1a‐alloimmunized pregnant woman. Using fluorescently labeled HPA‐1a‐positive platelets, single B‐cells were sorted and cultured for 10 days to stimulate antibody production. Subsequently, supernatants were tested for the presence of antibodies by enzyme‐linked immunosorbent assay and their reactivity towards HPA‐1a‐positive platelets. Amplification and sequencing of variable regions allowed the generation of monoclonal antibodies using a HEK‐Freestyle‐based expression system.

Results

Three platelet‐specific B‐cells were obtained and cloned of which two were specific for HPA‐1a, named D‐ and M‐204, while the third was specific for HLA class I, which was named L‐204.

Discussion

This study outlined an effective method for the isolation of HPA‐1a‐specific B‐cells and the generation of monoclonal antibodies. Further characterization of these antibodies holds promise for better understanding the pathogenic nature of alloantibodies in FNAIT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, Human PlateletThrombocytopenia, Neonatal AlloimmuneIsoantibodiesHumansPregnancyFemaleIntegrin beta3B-LymphocytesAntibodies, MonoclonalBlood PlateletsInfant, Newborn

Stichwörter der Autor:innen

FNAITHPA‐1aalloantibodiesantibody heterogeneitybleedingintegrins

Substanzen

Antigens, Human PlateletITGB3 protein, humanIsoantibodiesIntegrin beta3Antibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Experimental Immunohematology, Sanquin Research, Amsterdam, The Netherlands.
  • Department of Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.
  • Department of Pediatrics, Division of Neonatology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Department of Immunohematology Diagnostics, Sanquin Diagnostic Services, Amsterdam, The Netherlands.
  • Department of Immunogenetics, Sanquin Diagnostic Services, Amsterdam, The Netherlands.
  • Department of Haematology, Leiden University Medical Centre, Leiden, The Netherlands.

ORCID-Profile: Janita J Oosterhoff

Förderung

  • Landsteiner Foundation for Blood Transfusion Research

Zitieren

APA

Oosterhoff, J. J., Linty, F., Visser, R., de Vos, T., Hofstede-van Egmond, S., van de Weerd, M., Porcelijn, L., de Haas, M., van der Schoot, E., & Vidarsson, G. (2024). Generation of human antibodies targeting human platelet antigen ( HPA) ‐1a. Transfusion. https://doi.org/10.1111/trf.17758

Vancouver

Oosterhoff JJ, Linty F, Visser R, de Vos T, Hofstede-van Egmond S, van de Weerd M, et al. Generation of human antibodies targeting human platelet antigen ( HPA) ‐1a. Transfusion. 2024. doi:10.1111/trf.17758

BibTeX
@article{Oosterhoff2024,
  author = {Oosterhoff, Janita J and Linty, Federica and Visser, Remco and de Vos, Thijs and Hofstede-van Egmond, Suzanne and van de Weerd, Miranda and Porcelijn, Leendert and de Haas, Masja and van der Schoot, Ellen and Vidarsson, Gestur},
  title = {Generation of human antibodies targeting human platelet antigen ( HPA) ‐1a},
  journal = {Transfusion},
  year = {2024},
  doi = {10.1111/trf.17758}
}
Kostenlos starten →